Hamlet Pharma AB has shown that daily, long-term treatment with bovine α-lactalbumin made lethal to tumor cells (BAMLET) in drinking water inhibits intestinal tumor development in mice genetically susceptible to intestinal tumors, compared to mice not receiving BAMLET.